A detailed history of Morgan Stanley transactions in Inogen Inc stock. As of the latest transaction made, Morgan Stanley holds 1,276,844 shares of INGN stock, worth $10.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,276,844
Previous 1,036,990 23.13%
Holding current value
$10.4 Million
Previous $5.69 Million 80.99%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$5.26 - $10.15 $1.26 Million - $2.43 Million
239,854 Added 23.13%
1,276,844 $10.3 Million
Q4 2023

Feb 13, 2024

BUY
$4.21 - $6.32 $3.01 Million - $4.51 Million
713,815 Added 220.88%
1,036,990 $5.69 Million
Q3 2023

Nov 15, 2023

BUY
$5.14 - $11.28 $363,557 - $797,845
70,731 Added 28.02%
323,175 $1.69 Million
Q2 2023

Aug 14, 2023

BUY
$10.01 - $13.86 $101,651 - $140,748
10,155 Added 4.19%
252,444 $2.92 Million
Q1 2023

May 15, 2023

SELL
$11.88 - $26.0 $5.17 Million - $11.3 Million
-435,160 Reduced 64.24%
242,289 $3.02 Million
Q4 2022

Feb 14, 2023

BUY
$19.14 - $24.55 $10.6 Million - $13.6 Million
553,609 Added 447.04%
677,449 $13.4 Million
Q3 2022

Nov 14, 2022

BUY
$22.74 - $31.8 $175,325 - $245,178
7,710 Added 6.64%
123,840 $3.01 Million
Q2 2022

Oct 27, 2022

BUY
$22.88 - $35.28 $655,237 - $1.01 Million
28,638 Added 32.73%
116,130 $2.81 Million
Q2 2022

Aug 15, 2022

BUY
$22.88 - $35.28 $655,237 - $1.01 Million
28,638 Added 32.73%
116,130 $2.81 Million
Q1 2022

Oct 27, 2022

SELL
$28.1 - $35.25 $804,727 - $1.01 Million
-28,638 Reduced 24.66%
87,492 $2.84 Million
Q1 2022

May 13, 2022

SELL
$28.1 - $35.25 $549,692 - $689,560
-19,562 Reduced 18.27%
87,492 $2.84 Million
Q4 2021

Feb 14, 2022

BUY
$29.66 - $44.0 $434,578 - $644,688
14,652 Added 15.86%
107,054 $3.64 Million
Q3 2021

Nov 15, 2021

BUY
$43.09 - $82.26 $3.98 Million - $7.6 Million
92,402 New
92,402 $3.98 Million

Others Institutions Holding INGN

About Inogen Inc


  • Ticker INGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 22,866,500
  • Market Cap $186M
  • Description
  • Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...
More about INGN
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.